These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2730251)

  • 1. Hyperkalemia in diabetes mellitus. Effect of a triamterene-hydrochlorothiazide combination.
    Hollenberg NK; Mickiewicz C
    Arch Intern Med; 1989 Jun; 149(6):1327-30. PubMed ID: 2730251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmarketing surveillance in 70,898 patients treated with a triamterene/hydrochlorothiazide combination (Maxzide).
    Hollenberg NK; Mickiewicz CW
    Am J Cardiol; 1989 Jan; 63(4):37B-41B. PubMed ID: 2911994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PACT study: post-marketing surveillance in 47,465 patients treated with Maxzide (triamterene/hydrochlorothiazide). An interim report.
    Hollenberg NK; Bannon JA
    Am J Med; 1986 Apr; 80(4A):30-6. PubMed ID: 3518430
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of a hydrochlorothiazide plus triamterene combination (Dyazide) and atenolol in the treatment of patients with mild hypertension: a multicentre study in general practice.
    Philip IG; Qureshi SM; Richards HH; Sharma SK; Wright FG; Young PH; Rowley-Jones D
    Br J Clin Pract; 1987 Oct; 41(10):947-53. PubMed ID: 3333144
    [No Abstract]   [Full Text] [Related]  

  • 5. A new antihypertensive agent: Maxzide (75 mg triamterene/50 mg hydrochlorothiazide).
    Blume CD; Williams RL
    Am J Med; 1984 Nov; 77(5A):52-8. PubMed ID: 6388327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy and bioequivalence of a brand-name and a generic triamterene-hydrochlorothiazide combination product.
    Sharoky M; Perkal M; Tabatznik B; Cane RC; Costello K; Goodwin P
    Clin Pharm; 1989 Jul; 8(7):496-500. PubMed ID: 2752698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of potassium-sparing effects of triamterene and amiloride in the treatment with hydrochlorothiazide].
    Glezer GA; Merzon AK; Lipko DS; Donskova TV; Levinzon AM; Shelest IuP
    Klin Med (Mosk); 1990 Sep; 68(9):61-4. PubMed ID: 2290332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypokalemia during the treatment of arterial hypertension with diuretics.
    Lemieux G; Beauchemin M; Vinay P; Gougoux A
    Can Med Assoc J; 1980 Apr; 122(8):905-7. PubMed ID: 7370875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
    McClennen W; Wilson T
    Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive action of drug combination: Timolol, hydralazine, hydrochlorothiazide and triamterene.
    Pörsti P; Jalonen K; Ryysy L; Toivonen T; Viherkoski M
    Ann Clin Res; 1981 Feb; 13(1):6-10. PubMed ID: 7018363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of hypertension with a fixed calcium antagonist-diuretic combination. Observations from treatment of 5,595 patients].
    Klaus D
    Fortschr Med; 1995 Mar; 113(7):90-6. PubMed ID: 7750891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus.
    Fogari R; Derosa G; Zoppi A; Rinaldi A; Preti P; Lazzari P; Mugellini A
    Hypertens Res; 2008 Jan; 31(1):43-50. PubMed ID: 18360017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrochlorothiazide/triamterene combination: once daily in the treatment of hypertension.
    Zacharias FJ; Cornhill J
    Br J Clin Pract; 1984 May; 38(5):185-7. PubMed ID: 6733013
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal failure with potassium-sparing diuretics.
    Lynn KL; Bailey RR; Swainson CP; Sainsbury R; Low WI
    N Z Med J; 1985 Aug; 98(784):629-33. PubMed ID: 3861973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum and total body potassium during treatment with chlortalidone and hydrochlorothiazide. Influence of triamterene (author's transl)].
    Schäfer GE; Werner E; Kober G; Kaltenbach M
    Dtsch Med Wochenschr; 1977 Dec; 102(50):1838-43. PubMed ID: 590117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrochlorothiazide-amiloride versus hydrochlorothiazide alone for essential hypertension: effects on blood pressure and serum potassium level.
    Larochelle P; Logan AG
    Can Med Assoc J; 1985 Apr; 132(7):801-5. PubMed ID: 3884122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-blind, randomized, cross-over study of angiotensin-converting enzyme inhibitor and triamterene and hydrochlorothiazide in the treatment of mild to moderate hypertension in the elderly.
    Woo J; Woo KS; Kin T; Vallance-Owen J
    Arch Intern Med; 1987 Aug; 147(8):1386-9. PubMed ID: 2820329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with a new combination formulation of triamterene and hydrochlorothiazide (Maxzide) in patients with mild to moderate hypertension.
    Williams RL; Clark T; Blume CD
    Am J Med; 1984 Nov; 77(5A):62-6. PubMed ID: 6388328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in serum potassium levels occurring in patients treated with triamterene and a triamterene-hydrochlorothiazide combination.
    Hansen KB; Bender AD
    Clin Pharmacol Ther; 1967; 8(3):392-9. PubMed ID: 6026787
    [No Abstract]   [Full Text] [Related]  

  • 20. Indomethacin- and Moduretic--induced hyperkalemia.
    Mor R; Pitlik S; Rosenfeld JB
    Isr J Med Sci; 1983 Jun; 19(6):535-7. PubMed ID: 6862860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.